Psyence Biomedical Cash Flow Statement (2023-2025) | PBM

Cash Flow Statement Mar2023 Mar2024 Sep2024 Mar2025 Sep2025
Operating Activities
Net Income (Quarter) -3.23M1.16M-1.50M
Depreciation and Depletion (Quarter) 0.00M-0.00M
Cash from Operations (Quarter) -1.59M
Depreciation, Depletion & Amortization
Amortization (Quarter) 4.07-0.51
Depreciation & Amortization (CF) (Quarter) 0.00M-0.00M
Change in Working Capital
Change in Receivables (Quarter) -0.11M0.04M0.13M0.14M0.17M
Change in Accured Expenses (Quarter) 1.79M0.76M0.86M0.39M0.64M
Other Working Capital Changes (Quarter) -0.07M0.32M0.16M0.25M0.26M
Additional items
Change in Cash (Quarter) -0.42M
Free Cash Flow (Quarter) -1.59M
Net Cash Flow (Quarter) -1.59M